Calamos Advisors’s DarioHealth DRIO Stock Holding History

Calamos Advisors’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-807	Closed	-$311K	–	968
2021 Q1	$311K	Buy	+807	New	+$364K	﹤0.01%	852

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CHM

Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Calamos Advisors's DRIO Position: Q2 2021 in Review

Calamos Advisors sold out of DarioHealth (DRIO) in Q2 2021, closing a stake of 807 shares — an estimated $311K sold.

Calamos Advisors first reported a position in DRIO in Q1 2021 and held it in 1 quarter. The position peaked at $311K in Q1 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2021.

Calamos Advisors reported no remaining DarioHealth position as of Q2 2021 after selling out during the quarter.
Calamos Advisors sold 807 DarioHealth shares in Q2 2021, an estimated $311K.
Calamos Advisors first reported a position in DarioHealth in Q1 2021 and held it in 1 quarter.
Calamos Advisors's DarioHealth position peaked at $311K in Q1 2021.
58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2021.

Based on Calamos Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.